(Bloomberg) -- Novo Nordisk A/S is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly & Co.
Novo Boosts Wegovy Shipments as Lilly Rivalry Pressures Prices
02. May 2024 ACEST 14:18
Latest
Der er ikke flere artikler i listen
